Comorbid pain and opioid addiction: Psychosocial and pharmacological treatments

Substance Use and Misuse

Volumn 46, Issue 12, 2011, Pages 1536-1552

  Wachholtz, Amy ^a   Ziedonis, Douglas ^a   Gonzalez, Gerardo ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

chronic pain; complementary and alternative medicine; dependence; opioid addiction; pharmacology; psychological

Indexed keywords

NARCOTIC ANTAGONIST;

ALTERNATIVE MEDICINE; CHRONIC DISEASE; DEMOGRAPHY; HUMAN; METHODOLOGY; OPIATE ADDICTION; PAIN; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; REVIEW; STATISTICS; VALIDATION STUDY;

CHRONIC DISEASE; COMPLEMENTARY THERAPIES; DEMOGRAPHY; HUMANS; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PAIN; PSYCHOTHERAPY; VALIDATION STUDIES AS TOPIC;

EID: 80052089069     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.559606     Document Type: Article

References (132)

1. Adler, P., Good, M., Roberts, B., & Snyder, S. (2000). The effects of Tai Chi on older adults with chronic arthritis pain. Journal of Nursing Scholarship, 32, 377.
2. Alford, D. P., Compton, P., & Samet, J. H. (2006). Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Annals of Internal Medicine, 144, 127-134. (Pubitemid 46768231)
3. Amass, L., Kamien, J. B., & Mikulich, S. K. (2000). Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet. Drug & Alcohol Dependence, 58, 143-152.
4. Amass, L., Kamien, J. B., & Mikulich, S. K. (2001). Thriceweekly supervised dosing with the combination buprenorphinenaloxone tablet is preferred to daily supervised dosing by opioiddependent humans. Drug & Alcohol Dependence, 61, 173-181. (Pubitemid 32008531)
5. Arnold, R. M., Avants, S. K., Margolin, A., & Marcotte, D. (2002). Patient attitudes concerning the inclusion of spirituality into addiction treatment. Journal of Substance Abuse Treatment, 23, 319-326. (Pubitemid 36002031)
6. Avants, S. K., & Margolin, A. (1995). Self and addiction: The role of imagery in self-regulation. Journal of Alternative and Complementary Medicine, 1, 339-345.
7. Ballantyne, J. C., & LaForge, K. S. (2007). Opioid dependence and addiction during opioid treatment of chronic pain. Pain, 129, 235-255. (Pubitemid 46754581)
8. Barry,D. T., Beitel, M., Cutter, C. J., Joshi,D., Falcioni, J.,&Schottenfeld, R. (2010). Conventional and nonconventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: A needs assessment study. Journal of Addiction Medicine, 4(2), 81-87.
9. Blinderman, C. D., Sekine, R., Zhang, B., Nillson, M., & Shaiova, L. (2009). Methadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs (MMTPs). Journal of Opioid Management, 5, 107-114.
10. Brands, B., Blake, J., Sproule, B., Gourlay, D., & Busto, U. (2004). Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence, 73, 199-207. (Pubitemid 38068356)
11. Brennan, P. L., Schutte, K. K., & Moos, R. H. (2005). Pain and use of alcohol to manage pain: Prevalence and 3-year outcomes among older problem and non-problem drinkers. Addiction, 100, 777-786. (Pubitemid 40774873)
12. Brinkman, D. (1978). Biofeedback application to drug addiction in the University of Colorado drug rehabilitation program. International Journal of the Addictions, 13, 817-830. (Pubitemid 9076908)
13. Brown, R., Kraus, C., Fleming, M., & Reddy, S. (2004). Methadone: Applied pharmacology and use as adjunctive treatment in chronic pain. Postgraduate Medical Journal, 80, 654-659. (Pubitemid 39546060)
14. Bruce, R. (2006). Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: Implications and management for clinical practice. Journal of Acquired Immune Deficiency Syndrome, 41, 563-572.
15. Burke, B. L., Arkowitz, H., &Menchola, M. (2003). The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. Journal of Consulting and Clinical Psychology, 71, 843-861. (Pubitemid 37151548)
16. Carroll, K. M., Rounsaville, B. J., Nich, C., Gordon, L. T., Wirtz, P. W., & Gawin, F. H. (1994). One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: Delayed emergence of psychotherapy effects. Archives of General Psychiatry, 51, 989-997. (Pubitemid 24371869)
17. Carson, J., Keefe, F., Lynch, T., Carson, K., Goli, V., Fras, A., et al. (2005). Loving-kindness meditation for chronic low back pain: Results from a pilot trial. Journal of Holistic Nursing, 23, 287-304.
18. Centre for Addiction and Mental Health. (2001). Best practices: Concurrent mental health and substance abuse disorders. Ottawa: Health Canada.
19. Cheatle, M. D., & Gallagher, R. M. (2006). Chronic pain and comorbid mood and substance use disorders: A biopsychosocial treatment approach. Current Psychiatry Reports, 8, 371-376. (Pubitemid 44515389)
20. Collins, E. D., & Streltzer, J. (2003). Should opioid analgesics be used in themanagement of chronic pain in opiate addicts? American Journal on Addictions, 12, 93-100. (Pubitemid 36583418)
21. Compton, P., Darakjian, J., & Miotto, K. (1998). Screening for addiction in patients with chronic pain and "problematic" substance use: Evaluation of a pilot assessment tool. Journal of Pain and Symptom Management, 16, 355-363. (Pubitemid 29006198)
22. Compton, P., & Gebhart, G. F. (2003). The neurophysiology of pain and interfaces with addiction. In A. W. Graham (Ed.), Principles of addiction medicine (pp. 1385-1404). Chevy Chase, MD: American Society of Addiction Medicine.
23. Compton, W. M., & Volkow, N. D. (2006). Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence, 81, 103-107. (Pubitemid 41821793)
24. Cooper, J. R. (1995). Including narcotic addiction treatment in an office-based practice. Journal of the American Medical Association, 273, 1619-1620.
25. Cruciani, R. A., Sekine, R., Homel, P., Lussier, D., Yap, Y., Suzuki, Y., et al. (2005). Measurement of QTc in patients receiving chronic methadone therapy. Journal of Pain and Symptom Management, 29, 385-391. (Pubitemid 40602519)
26. Currie, S. R., Hodgins, D. C., Crabtree, A., Jacobi, J., & Armstrong, S. (2003). Outcome from integrated pain management treatment for recovering substance abusers. Journal of Pain, 4, 91-100. (Pubitemid 36337420)
27. Daley, D. C., & Marlatt, G. A. (1992). Relapse prevention: Cognitive and behavioral interventions. In J. H. Lowinson, P. Ruiz, R. B. Millman,&J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (pp. 533-542). Baltimore: Williams and Wilkins.
28. DHHS (Department of Health and Human Services, Drug Abuse Warning Network). (2004). National estimates of drug-related emergency department visits. Washington, DC: Author.
29. DiClemente, C. C., Schlundt, D., & Gemmell, L. (2004). Readiness and stages of change in addiction treatment. American Journal of Addiction, 13, 103-119. (Pubitemid 38585692)
30. Donald, M., Dower, J., & Kavanagh, D. J. (2005). Integrated versus nonintegrated management and care for clients with cooccurring mental health and substance abuse disorders: A qualitative systematic review of randomized controlled trials. Social Science & Medicine, 60, 1371-1383. (Pubitemid 40038765)
31. Dutra, L., Stathopoulou, G., Basden, S., Leyro, T., Powers, M. B.,& Otto, M. (2008). A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry, 165, 179-187. (Pubitemid 351704516)
32. Eccleston, C. (2001). Role of psychology in pain management. British Journal of Anesthesia, 87, 144-152. (Pubitemid 32631683)
33. Elliott, A. M., Smith, B.H., Penny, K. I., Smith,W. C.,&Chambers, W. A. (1999). The epidemiology of chronic pain in the community. Lancet, 354, 1248-1252. (Pubitemid 29469353)
34. Evers, A. W. M., Kraaimaat, F. W., Geenen, R., Jacobs, J. W. G., & Bijlsma, J. W. J. (2003). Pain coping and social support as predictors of long-term functional disability and pain in early rheumatoid arthritis. Behaviour Research and Therapy, 41, 1295-1310. (Pubitemid 37188370)
35. Ezzo, J., Berman, B., Hadhazy, V. A., Jadad, A. R., Lao, L., & Singh, B. B. (2000). Is acupuncture effective for the treatment of chronic pain? A systematic review. Pain, 86, 217-225. (Pubitemid 30254262)
36. Fiellin, D. A., Pantalon, M. V., Pakes, J. P., O'Connor, P. G., Chawarski, M., & Schottenfeld, R. S. (2002). Treatment of heroin dependence with buprenorphine in primary care. American Journal of Drug & Alcohol Abuse, 28, 231-241. (Pubitemid 34457057)
37. Fishbain, D. A., Rosomoff, H. L., Steele, R., & Rosomoff, R. (1992). Drug abuse, dependence, and addiction in chronic pain patients. Clinical Journal of Pain, 8, 77-85.
38. Flor, H., Knost, B., & Birbaumer, N. (2002). The role of operant conditioning in chronic pain: An experimental investigation. Pain, 95, 111-118. (Pubitemid 34076782)
39. Fordyce, W. E. (1976). Behavioral methods for chronic pain and illness. Saint Louis, MO: Mosby.
40. Fudala, P. J., Bridge, T. P., & Herbert, S. (1998). Buprenorphine/ Naloxone Collaborative Study Group. A multisite efficacy evaluation of a buprenorphine/naloxone product for opiate dependence treatment. In L. S. Harris (Ed.), Problems of drug dependence (NIDA Research Monograph No. 179, pp. 105). Washington, DC: Government Printing Office.
41. Gatantino, M. L., Bzdewka, T. M., Eissler-Rnsso, J. L., Holbrook, M. L.,Mogck, E. P., Geigle, P., et al. (2004). The impact of modified Hatha Yoga on chronic low back pain: A pilot study. Alternative Therapies in Health & Medicine, 10, 56-59. (Pubitemid 38339424)
42. Gil, K. M., Ross, S. L., & Keefe, F. J. (1988). Behavioral treatment of chronic pain: Four pain management protocols. In R. D. France & R. Krishnan (Eds.), Chronic pain (pp. 376-413). Washington, DC: American Psychiatric Press.
43. Gilson, A. M., Ryan, K. M., Joranson, D. E., & Dahl, J. L. (2004). A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. Journal of Pain and Symptom Management, 28, 176-188. (Pubitemid 38970078)
44. Gonzalez, G., Oliveto, A., & Kosten, T. R. (2004). Combating opiate dependence: A comparison among the available pharmacological options. Expert Opinions in Pharmacotherapeutics, 5, 713-725. (Pubitemid 38489498)
45. Graham, N. A., Merlo, L. J., Goldberger, B. A., & Gold, M. S. (2008). Methadone and heroin-related deaths in Florida. American Journal of Drug and Alcohol Abuse, 34, 347-353.
46. Habib, S., Morrissey, S., & Helmes, E. (2005). Preparing for pain management: A pilot study to enhance engagement. Journal of Pain, 6, 48-54. (Pubitemid 40052001)
47. Hayes, S. C., Wilson, K. G., Gifford, E. V., Bissett, R., Piasecki, M., Batten, S. V., et al. (2004). A preliminary trial of twelvestep facilitation and acceptance and commitment therapy with polysubstance-abusing methadone-maintained opiate addicts. Behavior Therapy, 35, 667-688. (Pubitemid 41065015)
48. Hojsted, J., & Sjogren, P. (2007). Addiction to opioids in chronic pain patients: A literature review. European Journal of Pain, 11, 490-518. (Pubitemid 46670780)
49. Huestis, M. A., Umbricht, A., & Preston, K. L. (1999). Safety of buprenorphine: No clinically relevant cardio-respiratory depression at high IV doses. In L. S. Harris (Ed.), Problems of drug dependence (pp. 62). Washington, DC: U.S. Government Printing Office.
50. Humphreys, K., Wing, S., McCarty, D., Chappel, J., Gallant, L., Haberle, B., et al. (2004). Self-help organizations for alcohol and drug problems: Toward evidence-based practice and policy. Journal of Substance Abuse Treatment, 26, 151-158. (Pubitemid 38452833)
51. Ives, T. J., Chelminski, P. R., Hammett-Stabler, C. A., Malone, R. M., Perhac, J. S., Potisek, N.M., et al. (2006). Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Services Research, 6, 46.
52. Johnson, R. E., Fudala, P. J., & Payne, R. (2005). Buprenorphine: Considerations for painmanagement. Journal of Pain and Symptom Management, 29, 297-326.
53. Jordan, J. (2006). Acupuncture treatment for opiate addiction: A systematic review. Journal of Substance Abuse Treatment, 30, 309-314. (Pubitemid 43729148)
54. Kabat-Zinn, J., Lipworth, L., Burney, R., & Sellers, W. (1986). Four-year follow-up of a meditation based program for the selfregulation of chronic pain: Treatment outcomes and compliance. Clinical Journal of Pain, 2, 159-173. (Pubitemid 17028832)
55. Keefe, F. J.,Gil, K. M.,&Rose, S. C. (1986). Behavioral approaches in the multidisciplinary management of chronic pain: Programs and issues. Clinical Psychology Review, 6, 87-113. (Pubitemid 16120436)
56. Khatami, M.,Woody, G., O'Brien, C., &Mintz, J. (1982). Biofeedback treatment of narcotic addiction: A double-blind study. Drug and Alcohol Dependence, 9, 111-117. (Pubitemid 12038813)
57. Kosten, T. R., Morgan, C., & Kleber, H. D. (1991). Treatment of heroin addicts using buprenorphine. American Journal of Drug & Alcohol Abuse, 17, 119-128.
58. Kouyanou, K., Pither, C. E., &Wessely, S. (1997).Medication misues, abuse, and dependence in chronic pain patients. Journal of Psychosomatic Research, 43, 497-504. (Pubitemid 27487541)
59. Krantz, M. J., Lewkowiez, L., Hays, H.,Woodroffe, M. A., Robertson, A. D.,&Mehler, P. S. (2002). Torsade de pointes associated with very-high-dose methadone. Annals of Internal Medicine, 137, 501-504. (Pubitemid 35024621)
60. Krantz,M. J., Martin, J., Stimmel, B.,Mehta, D., & Haigney, M. C. (2009). QTc interval screening in methadone treatment. Annals of Internal Medicine, 150(6), 387-395.
61. Kreek, M. J. (2000). Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Science, 909, 186-216.
62. Kuhlman, J. J., Levine, B., Johnson, R. E., Fudala, P. J., & Cone, E. J. (1998). Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction, 93, 549-559. (Pubitemid 28188074)
63. Lange, W. R., Fudala, P. J., Dax, E. M., & Johnson, R. E. (1990). Safety and side-effects of buprenorphine in the clinical management of heroin addiction. Drug and Alcohol Dependence, 26, 19-28. (Pubitemid 20254839)
64. Larson, M. J., Paasche-Orlow, M., & Cheng, D. M. (2007). Persistent pain is associated with substance use after detoxification: A prospective cohort analysis. Addiction, 102, 752-760. (Pubitemid 46633356)
65. Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., et al. (1998). Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction, 93, 475-486. (Pubitemid 28188067)
66. Mamtani, R.,&Cimino, A. (2002). A primer of complementary and alternative medicine and its relevance in the treatment of mental health problems. Psychiatric Quarterly, 73, 367-381. (Pubitemid 38429498)
67. Margolin, A., Avants, S. K., & Kosten, T. R. (1994). Cue-elicited cocaine craving and autogenic relaxation. Association with treatment outcome. Journal of Substance Abuse Treatment, 11, 549-552.
68. Martell, B. A., Arnsten, J. H., Ray, B., & Gourevitch, M. N. (2003). The impact of methadone induction on cardiac conduction in opiate users. Annals of Internal Medicine, 139, 154-155. (Pubitemid 38129111)
69. Martell, B. A., O'Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R., et al. (2007). Systematic review: Apioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Annals of Internal Medicine, 146, 116-127. (Pubitemid 351640015)
70. Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2003). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, CD002209.
71. Mayet, S., Farrell, M., Ferri, M. M. F., Amato, L., & Davoli, M. (2004). Psychosocial treatment for opiate abuse and dependence. Cochrane Database of Systematic Reviews, CD004330.
72. Meldrum, M. (2003). A capsule history of pain management. Journal of the American Medical Association, 290, 2470-2475. (Pubitemid 37430547)
73. Mertens, J. R., Lu, Y. W., Parthasarathy, S., Moore, C., & Weisner, C. M. (2003). Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO. Archives of Internal Medicine, 163, 2511-2517. (Pubitemid 37385795)
74. Miller, A., Hall, C., & Buchanan, R. (2004). The Texas medication algorithm project antipsychotic algorithm for schizophrenia: 2003 update. Journal of Clinical Psychiatry, 65, 500-508.
75. Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York: Guilford Press.
76. Molton, I. R. G., Stoelb, C.,&Jensen, B. L. (2007). Current psychological approaches to the management of chronic pain. Current Opinion in Anasthesiology, 20, 485-489.
77. Morley, S., Eccleston, C.,&Williams,A. (1999). Systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy and behavior therapy for chronic pain in adults, excluding headache. Pain, 80, 1-13. (Pubitemid 29151684)
78. Morone,N. E.,&Greco, C.M. (2007).Mind-body interventions for chronic pain in older adults: A structured review. Pain Medicine, 8, 359-375. (Pubitemid 47039420)
79. Mueser, K., Drake, R., &Wallach,M. (1998). Dual diagnosis: A review of etiological theories. Addictive Behaviors, 23, 717-734. (Pubitemid 28443188)
80. National Institutes of Health. (1998). NIH consensus development conference on acupuncture. Journal of the American Medical Association, 280, 1518-1524.
81. Neufeld, K., Kidorf, M., Kolodner, K., King, V., Clark, M., & Brooner, R. (2008). A behavioral treatment for opioiddependent patients with antisocial personality. Journal of Substance Abuse Treatment, 34, 101-111. (Pubitemid 350216357)
82. Novick, D. M., Joseph, H., Salsitz, E. A., Kalin, M. F., Keefe, J. B., Miller, E. L., et al. (1994). Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices (medical maintenance): Follow-up at three and a half to nine and a fourth years. Journal of General Internal Medicine, 9, 127-130. (Pubitemid 24114745)
83. Novick, D. M., Pascarelli, E. F., & Joseph, H. (1988). Methadone maintenance patients in general medical practice. A preliminary report. Journal of the American Medical Association, 259, 3299-3302.
84. Penzien, D. B., Rains, J. C., & Andrasik, F. (2002). Behavioral management of recurrent headache: Three decades of experience and empiricism. Applied Psychophysiology and Biofeedback, 27, 163-181. (Pubitemid 34848001)
85. Petry, N. M., Bickel,W. K., & Badger, G. J. (2001). Examining the limits of the buprenorphine interdosing interval: Daily, everythird- day and every-fifth-day dosing regimens. Addiction, 96, 823-834.
86. Petry, N. M., & Martin, B. (2002). Low-cost contingency management for treating cocaine- and opioid abusing methadone patients. Journal of Consulting and Clinical Psychology, 70, 398-405. (Pubitemid 34274884)
87. Portenoy, R. K. (1990). Chronic opioid therapy in non-malignant pain. Journal of Pain and Symptom Management, 5, S46-S62. (Pubitemid 20156198)
88. Potter, J., Shiffman, S., & Weiss, R. (2008). Chronic pain severity in opioid-dependent patients. American Journal of Drug and Alcohol Abuse, 34, 101-107.
89. Prater, C. D., Zylstra, R. G., &Miller, K. E. (2002). Successful pain management for the recovering addicted patient. Primary Care Companion to the Journal of Clinical Psychiatry, 4, 125-131.
90. Prochaska, J. O., & DiClemente, C. C. (1986). Toward a comprehensive model of change. In W. R. Miller & N. Heather (Eds.), Treating addictive behavior: Processes of change (pp. 3-27). New York: Plenum Press.
91. Purdue Pharma. (2009). FDA advisory committee briefing document on NDA 22-272 (reformulated OxyContin R-tablets). Retrieved November 4, 2009, from http://www.fda.gov/downloads/AdvisoryCommittees/Committe esMeetingMaterials/ Drugs/AnestheticAndLifeSupportDrugsAd visoryCommittee/UCM183205.pdf
92. Rance, M. J., & Dickens, J. N. (1978). The influence of drugreceptor kinetics on the pharmacological and pharmaco-kinetic profiles of buprenorphine. In J. M. Van Ree & L. Pereniums (Eds.), Characteristics and function of opioids (pp. 65-66). Amsterdam: Elsevier/North-Holland Biomedical Press.
93. Rau, J., Ehlebracht-König, I., & Petermann, F. (2008). Impact of a motivational intervention on coping with chronic pain: Results of a controlled efficacy study [abstract only; article in German]. Schmerz, 22, 575-578, 580-585.
94. Reiger, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association, 19, 2511-2518.
95. Reilly, R. L. (1994). Adapting the twelve-step approach to chronic pain. Behavioral Health Management, 14, 2.
96. Resnick, R. B., Galanter, M., Pycha, C., Cohen, A.,Grandison, P.,& Flood, N. (1992). Buprenorphine: An alternative to methadone for heroin dependence treatment. Psychopharmacology Bulletin, 28, 109-113.
97. Resnick, R. B., Resnick, E., & Galanter, M. (1991). Buprenorphine responders: A diagnostic subgroup of heroin addicts? Progress in Neuro-Psychopharmacology & Biological Psychiatry, 15, 531-538.
98. Rhodin, A., Gronbladh, L., Nilsson, L. H., & Gordh, T. (2006). Methadone treatment of chronic non-malignant pain and opioid dependence: A long-term follow-up. European Journal of Pain, 10, 271-278. (Pubitemid 43255214)
99. Roper-Starch Worldwide. (1999). Chronic pain in America: Roadblocks to relief. Retrieved March 18, 2009, from http://www.ampainsoc.org/links/ roadblocks/index.htm#toc.
100. Rosenblum, A., Joseph, H., Fong, C., Kipnis, S., Cleland, C., & Portenoy, R.K. (2003). Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. Journal of the American Medical Association, 289, 2370-2378. (Pubitemid 37430169)
101. Rosenzweig, S., Greeson, J. M., Reibel, D. K., Green, J. S., Jasser, S. A., & Beasley, D. (2010).Mindfulness-based stress reduction for chronic pain conditions: Variation in treatment outcomes and role of home meditation practice. Journal of Psychosomatic Research, 68, 29-36.
102. Rounsaville, B. J., & Carroll, K. M. (1997). Individual psychotherapy for drug abusers. In J. H. Lowinsohn, P. Ruiz, & R. B. Miller (Eds.), Comprehensive textbook of substance abuse (pp. 430-439). New York: Williams & Wilkins.
103. Rounsaville, B. J., & Kleber, H. D. (1985). Psychotherapy/ counseling for opiate addicts: Strategies for use in different treatment settings. International Journal of Addiction, 20, 869-896. (Pubitemid 16184331)
104. Rubak, S., Sandbaek,A.,&Lauritzen, T. (2005).Motivational interviewing: Asystematic reviewandmeta-analysis. British Journal of General Practice, 55, 305-312.
105. SAMSHA. (2002). Report to congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders. Rockville, MD: US Department of Health and Human Services.
106. SAMSHA. (2005). Assessment and treatment of patients with coexisting mental illness and alcohol and other drug abuse. Treatment improvement protocol (TIP) series. Rockville, MD: US Department of Health and Human Services
107. Savage, S. R. (2002). Assessment for addiction in pain treatment settings. Clinical Journal of Pain, 18, S28-S38. (Pubitemid 34815392)
108. Savage, S. R., Joranson, D. E., Covington, E. C., Schnoll, S. H., Heit, H. A., & Gilson, A. M. (2003). Definitions related to the medical use of opioids: Evolution towards universal agreement. Journal of Pain and Symptom Management, 26, 655-667. (Pubitemid 36802289)
109. Seybold, K. (2007). Physiological mechanisms involved in religiosity/ spirituality and health. Journal of Behavioral Medicine, 30, 303-309.
110. Silverman, S. M. (2009). Opioid induced hyperalgesia: Clinical implications for the pain practitioner. Pain Physician, 12, 679-684.
111. Stetter, F., & Kupper, S. (2002). Autogenic training: A metaanalysis of clinical outcome studies. Applied Psychophysiology and Biofeedback, 27, 45-98. (Pubitemid 34327119)
112. Stitzer, M. L., Iguchi, M. Y., & Felch, L. J. (1992). Contingent take-home incentives: Effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology, 60, 927-934.
113. Stitzer,M., & Petry, N. (2006). Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology, 2, 411-434. (Pubitemid 43799812)
114. Streltzer, J., & Kosten, T. R. (2003). Methadone maintenance therapy and chronic pain [letter]. Journal of the American Medical Association, 290, 2403.
115. Syrjala, K. L., Donaldson, G. W., Davis, M. W., Kippes, M. E., & Carr, J. E. (1995). Relaxation and imagery and cognitivebehavioral training reduce pain during cancer treatment: A controlled clinical trial. Pain, 63, 189-198.
116. Tunks, E. R., Crook, J.,&Weir, R. (2008). Epidemiology of chronic pain with psychological comorbidity: Prevalence, risk, course, and prognosis. Canadian Journal of Psychiatry, 53, 224-234. (Pubitemid 351838516)
117. Turk, D. C. (2008). Perspectives on chronic pain: The role of psychological factors. Current Directions in Psychological Science, 3, 45-48.
118. Turner, J. A., & Clancy, S. (1988). Comparison of operant behavioral and cognitive-behavioral group treatment for chronic low back pain. Journal of Consulting and Clinical Psychology, 56, 261-266.
119. Vallejo, Z., & Amaro, H. (2009). Adaptation of mindfulness-based stress reduction program for addiction relapse prevention. The Humanistic Psychologist, 37, 192-206.
120. Wachholtz, A. B., & Pargament, K. (2005). Is spirituality a critical ingredient of meditation? Comparing the effects of spiritual meditation, secular meditation, and relaxation on spiritual, psychological, cardiac, and pain outcomes. Journal of Behavioral Medicine, 28, 369-384. (Pubitemid 41545599)
121. Wachholtz, A. B., & Pargament, K. (2008). Migraines and meditation: Does spirituality matter? Journal of Behavioral Medicine, 31, 351-366.
122. Wachholtz, A. B., Pearce, M., & Koenig, H. (2007). Exploring the relationship between spirituality, coping, and pain: Past research and future directions. Journal of Behavioral Medicine, 30, 311-318.
123. Walsh, S. L., Preston, K. L., Bigelow, G. E.,&Stitzer,M. L. (1995). Acute administration of buprenorphine in humans: Partial agonist and blockade effects. Journal of Pharmacology & Experimental Therapeutics, 274, 361-372.
124. Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994). Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clinical Pharmacology & Therapeutics, 55, 569-580. (Pubitemid 24192243)
125. Ward, J., Bell, J., & Mattick, R. P. (1996). Methadone maintenance therapy for opioid dependence: A guide to appropriate use. In J. Ward, R. P. Mattick, & W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 440-449). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
126. Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the opioid risk tool. Pain Medicine, 6, 432-442. (Pubitemid 43110296)
127. Weinstein, S. M., Laux, L. F., Thornby, J. I., Lorimor, R. J., Hill, C. S., Thorpe, D. M., et al. (2000). Physicians' attitudes toward pain and the use of opioid analgesics: Results of a survey from the Texas cancer pain initiative. Southern Medical Journal, 93, 479-487. (Pubitemid 30366226)
128. Weissman, D. E., & Haddox, J. D. (1989). Opioid pseudoaddiction. Pain, 36, 363-366.
129. Woody, G. E., McLellan, A. T., Luborsky, L., & O'Brien, C. P. (1987). Twelve-month follow-up of psychotherapy for opiate dependence. American Journal of Psychiatry, 144, 590-596. (Pubitemid 17067332)
130. Zgierska, A., Rabago, D., Chawla, N., Kushner, K., Koehler, R., & Marlatt, A. (2009). Mindfulness meditation for substance use disorders: A systematic review. Substance Abuse, 30, 266-294.
131. Ziedonis, D. M. (2004). Integrated treatment of co-occurring mental illness and addiction: Clinical intervention, program, and system perspectives. CNS Spectrum, 9, 892-904.
132. Ziedonis, D. M., Berman, J., Lehn, M. D., & Coameco, S. (2008). Support groups and twelve-step programs in the treatment of the chronic pain patient. In H. S. Smith & S. D. Passik (Eds.), Pain and chemical dependency (pp. 271-284). New York: Oxford University Press.